The overview discusses fifty eight peptides in numerous clinical phases, indicating a robust pipeline of peptide therapies targeting PPIs.Peptides are on the leading edge of modern research For brand new strong, selective, and safe therapeutical brokers. Their increase has reshaped the pharmaceutical landscape, providing solutions to problems that